HSPA5 and lung carcinoma: All these results suggested that blocking the activity of GRP78 would significantly enhance both lung cancer cells and myofibroblasts susceptibility to anticancer drug VP-16, thereby eliminating both the lung cancer cells and its surrounding stroma.